ProCE Banner Activity

Shifting the Treatment Paradigm of Weight Management and Type 2 Diabetes in Primary Care

Slideset

Leading experts in diabetes discuss the evidence and guidelines around appropriate incretin-based therapy for obesity and type 2 diabetes, from Clinical Education Alliance (CEA).

Released: June 05, 2023

Share

Faculty

Martin J. Abrahamson

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine
Harvard Medical School
Director, Division of CME
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Debbie Hinnen

Debbie Hinnen, APN, BC-ADM, CDCES, FAAN

Certified Diabetes Care and Education Specialist
Consultant, University of Colorado Health
Colorado Springs, Colorado

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange

ProCE Banner
ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Disclosure

Primary Author

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine
Harvard Medical School
Director, Division of CME
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Martin J. Abrahamson, MD, FACP, has no relevant financial relationships to disclose.

Debbie Hinnen, APN, BC-ADM, CDCES, FAAN

Certified Diabetes Care and Education Specialist
Consultant, University of Colorado Health
Colorado Springs, Colorado

Debbie Hinnen, APN, BC-ADM, CDCES, FAAN, FADCES: consultant/advisor/speaker: Intuity, Lilly/Boehringer Ingelheim, Novo Nordisk, Sanofi.

Contributing Author
Amy Butts, PA-C:
consultant/advisor/speaker: Abbott, Bayer, Novo Nordisk, Sanofi.